Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patientsRebecca Evans, Emmanuel Mignot, Haruhide Kimura et al.|Proceedings of the National Academy of Sciences|2022Cited by 92
Recruitment of trial participants through electronic medical record patient portal messaging: A pilot studyTimothy B. Plante, Lynne Hammann, Kristen McArthur et al.|Clinical Trials|2019Cited by 41